Adenosine A2 Receptor Agonists
"Adenosine A2 Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that selectively bind to and activate ADENOSINE A2 RECEPTORS.
Descriptor ID |
D058908
|
MeSH Number(s) |
D27.505.519.625.725.200.100.200 D27.505.696.577.725.200.100.200
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adenosine A2 Receptor Agonists".
Below are MeSH descriptors whose meaning is more specific than "Adenosine A2 Receptor Agonists".
This graph shows the total number of publications written about "Adenosine A2 Receptor Agonists" by people in this website by year, and whether "Adenosine A2 Receptor Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2012 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2014 | 2 | 1 | 3 |
2016 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenosine A2 Receptor Agonists" by people in Profiles.
-
Regadenoson Stress Perfusion Cardiac Magnetic Resonance Imaging in Children With Kawasaki Disease and Coronary Artery Disease. Am J Cardiol. 2019 10 01; 124(7):1125-1132.
-
Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema. Dis Model Mech. 2019 05 15; 12(5).
-
Myocardial Stress Perfusion MRI: Experience in Pediatric and Young-Adult Patients Following Arterial Switch Operation Utilizing Regadenoson. Pediatr Cardiol. 2018 Aug; 39(6):1249-1257.
-
Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson. Pediatr Radiol. 2017 Mar; 47(3):280-289.
-
Macrophage A2A Adenosine Receptors Are Essential to Protect from Progressive Kidney Injury. Am J Pathol. 2016 10; 186(10):2601-13.
-
Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials. J Nucl Cardiol. 2015 Oct; 22(5):1008-18.
-
Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials. J Nucl Cardiol. 2015 Apr; 22(2):248-61.
-
Adenosine regulates the proinflammatory signaling function of thrombin in endothelial cells. J Cell Physiol. 2014 Sep; 229(9):1292-300.
-
Assessment of perfusion and wall-motion abnormalities and transient ischemic dilation in regadenoson stress cardiac magnetic resonance perfusion imaging. Int J Cardiovasc Imaging. 2014 Jun; 30(5):949-57.
-
The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial. J Nucl Cardiol. 2014 Jun; 21(3):496-502.